Actemra failed a global, randomized, double-blind, placebo-controlled phase III trial investigating COVID-19 treatment, Roche announced on Wednesday.
The...
Tag - actemra
A new study found that critically ill COVID-19 patients were 45% less likely to die if given a single dose of the rheumatoid arthritis drug tocilizumab...
The rheumatoid arthritis drug Actemra failed to reduce severe respiratory symptoms, intensive care visits or deaths in a recent Italian study. Roche is...
A new study found that arthritis medication Actemra cut the death rate of severely-ill COVID-19 patients by 45%.
Some COVID-19 patients develop cytokine...
The results of a new study from China suggest that cytokine storms in COVID-19 patients may promote the death of T cells.
T cells are a critical component of...
Recent COVID-19 trial results suggest the arthritis drug Kevzara may only help critically ill COVID-19 patients whereas the arthritis drug Actemra may help a...
Hundreds of patients in the U.K.’s National Health Service (NHS) will be given the arthritis drug Actemra (tocilizumab) in the world’s largest clinical...
Pfizer plans to begin testing of its arthritis medication Xeljanz (tofacitinib) in COVID-19 patients in Italy this week.
Xeljanz is a janus kinase (JAK)...
The FDA has approved a randomized, double-blind, placebo-controlled phase III study into the efficacy and safety of intravenous Actemra (tocilizumab) for...
China has approved the rheumatoid arthritis drug Actemra (tocilizumab) for treatment of severe complications from COVID-19, the disease caused by the...